16
Antimicrobials and risks for antibiotic- associated diarrhea (AAD) Antibiotic-associated diarrhea 5-30% risk Higher with multiple IV drugs Higher with broad spectrum antimicrobials Higher with pediatric patients High with oral beta lactams Clostridium difficile may be involved Big reason for lack of compliance with therapy

Antimicrobials and risks for antibiotic-associated diarrhea (AAD) Antibiotic-associated diarrhea 5-30% risk Higher with multiple IV drugs Higher with broad

  • View
    220

  • Download
    1

Embed Size (px)

Citation preview

Page 1: Antimicrobials and risks for antibiotic-associated diarrhea (AAD) Antibiotic-associated diarrhea 5-30% risk Higher with multiple IV drugs Higher with broad

Antimicrobials and risks for antibiotic-associated diarrhea (AAD)

•Antibiotic-associated diarrhea

•5-30% risk

•Higher with multiple IV drugs

•Higher with broad spectrum antimicrobials

•Higher with pediatric patients

•High with oral beta lactams

•Clostridium difficile may be involved

•Big reason for lack of compliance with therapy

•Big reason for need to switch and to increase patient exposure to antimicrobials

•Probiotics use can help prevent

Page 2: Antimicrobials and risks for antibiotic-associated diarrhea (AAD) Antibiotic-associated diarrhea 5-30% risk Higher with multiple IV drugs Higher with broad

Stop Antibiotic

Start Antibiotic

Start Yeast (within 48h)

Stop Study

Yeast continued for 14d

Saccharomyces boulardii and Antibiotic Associated Diarrhea in Hospitalized PatientsN=180; site: University of Washington, Harborview Hospital

Page 3: Antimicrobials and risks for antibiotic-associated diarrhea (AAD) Antibiotic-associated diarrhea 5-30% risk Higher with multiple IV drugs Higher with broad

Surawicz et al., Gastroenterol. 1989;96:981

Page 4: Antimicrobials and risks for antibiotic-associated diarrhea (AAD) Antibiotic-associated diarrhea 5-30% risk Higher with multiple IV drugs Higher with broad

AAD D’Souza et al., BMJ 2002;324:1361

Page 5: Antimicrobials and risks for antibiotic-associated diarrhea (AAD) Antibiotic-associated diarrhea 5-30% risk Higher with multiple IV drugs Higher with broad

Clostridium difficile disease (pseudomembranous colitis)(CDD)

is a spore former anaerobe resistant to most antimicrobials

•is held in check by the normal flora but can overgrow if flora is perturbed

•any antimicrobial can initiate overgrowth; stomach acid suppression therapy can increase risk

•C. difficle makes two toxins which cause diarrhea to colitis to pseudomembranous colitis to toxic megacolon to death

•Can be treated with metronidazole (250mg QID) or vancomycin PO (125mg QID or 500mg QID) but relapse rate is ~20%

•Patients who relapse can have recalcitrant disease with ~50% relapse rate

•Probiotics can decrease rate of relapse but only Sacccharomyces boulardii has been tested and shown to help

Page 6: Antimicrobials and risks for antibiotic-associated diarrhea (AAD) Antibiotic-associated diarrhea 5-30% risk Higher with multiple IV drugs Higher with broad
Page 7: Antimicrobials and risks for antibiotic-associated diarrhea (AAD) Antibiotic-associated diarrhea 5-30% risk Higher with multiple IV drugs Higher with broad
Page 8: Antimicrobials and risks for antibiotic-associated diarrhea (AAD) Antibiotic-associated diarrhea 5-30% risk Higher with multiple IV drugs Higher with broad
Page 9: Antimicrobials and risks for antibiotic-associated diarrhea (AAD) Antibiotic-associated diarrhea 5-30% risk Higher with multiple IV drugs Higher with broad

McFarland et al., JAMA; 271, 1913-1918, (1994).

Page 10: Antimicrobials and risks for antibiotic-associated diarrhea (AAD) Antibiotic-associated diarrhea 5-30% risk Higher with multiple IV drugs Higher with broad

S. boulardiiS. boulardii & High Dose & High Dose Vancomycin for Vancomycin for C. difficileC. difficile Disease Disease

[Results][Results]

0

10

20

30

40

50

60

% CDD recurrences

50%

16.7%*

Surawicz CM. Clin Infect Dis 2000;31:1012-7.

S. boulardii (n=18)

Placebo(n=14)

*p=0.05

Page 11: Antimicrobials and risks for antibiotic-associated diarrhea (AAD) Antibiotic-associated diarrhea 5-30% risk Higher with multiple IV drugs Higher with broad

Copyright restrictions may apply.

Dial, S. et al. JAMA 2005;294:2989-2995.

Rates of Clostridium difficile per 100 000 Patients in the United Kingdom General Practice Research Database

Page 12: Antimicrobials and risks for antibiotic-associated diarrhea (AAD) Antibiotic-associated diarrhea 5-30% risk Higher with multiple IV drugs Higher with broad
Page 13: Antimicrobials and risks for antibiotic-associated diarrhea (AAD) Antibiotic-associated diarrhea 5-30% risk Higher with multiple IV drugs Higher with broad
Page 14: Antimicrobials and risks for antibiotic-associated diarrhea (AAD) Antibiotic-associated diarrhea 5-30% risk Higher with multiple IV drugs Higher with broad

Lactobacillus rhamnosus GG Dietary Supplement: Culturelle

Page 15: Antimicrobials and risks for antibiotic-associated diarrhea (AAD) Antibiotic-associated diarrhea 5-30% risk Higher with multiple IV drugs Higher with broad

Saccharomyces boulardii Dietary Supplement: Florastor

Page 16: Antimicrobials and risks for antibiotic-associated diarrhea (AAD) Antibiotic-associated diarrhea 5-30% risk Higher with multiple IV drugs Higher with broad